JPMorgan initiates SanDisk stock coverage with Neutral rating, citing AI exposure

SanDisk reported stronger-than-expected results with third-quarter revenue of $2.31 billion versus a $2.15 billion consensus and guided fourth-quarter revenue up ~13% q/q to $2.6 billion with gross margins rising to roughly 42%. JPMorgan initiated coverage with a Neutral rating and $235 price target, noting SanDisk's cost advantage via its Kioxia JV but smaller AI exposure than peers and concern that 2027 capacity expansions could return the memory market to a boom-bust cycle. Multiple analysts raised targets (Bernstein $300, Goldman $280, Jefferies and Mizuho $250), while the stock has rallied dramatically year-to-date, leaving a balanced risk-reward ahead of the next reported results on December 19.

Analysis

Market structure: The immediate winners are NAND-focused suppliers and hyperscalers buying high-density eSSDs (SNDK, Kioxia JV partners); losers are marginal, high-cost memory producers whose margins compress as price normalization returns. SanDisk’s current guidance (Q4 rev +13% q/q to ~$2.6B; gross margin ~42%) implies near-term pricing power, but planned industry capacity additions starting 2027 create a credible supply overhang that can reverse pricing — think a 20–40% revenue/margin swing across the cycle for exposed names.

Risk assessment: Tail risks include a 2027 capex wave that increases NAND supply >15% YoY, a major hyperscaler design pivot away from eSSD, or a geo-political disruption to the Kioxia JV (operational/regulatory) — any of which could drop SNDK >40% from current levels. Time horizons: expect volatility around Dec 19 earnings (days), normalization risk in 6–18 months as end-market growth matures, and structural industry risk from 2027 onward; hidden dependency: hyperscaler inventory stocking can amplify booms/busts by ±2-3 quarters.

Trade implications: Tactical reward-to-risk favors a small, hedged long into Dec 19 (capture further margin upside) but avoid naked exposure into 2027; favor buying convexity via call spreads into Jan 2026 to limit downside while keeping upside to $300+. Rotate modestly out of pure DRAM/capex-heavy names into NAND-cost-advantaged names (SNDK) and select semicap names benefiting from current pricing.

Contrarian angles: Consensus prizes near-term earnings and AI demand but underweights the 2027 capacity cliff — the market may be overpaying for transient margin expansion (current YTD move >300%, InvestingPro +535%). Historical parallels: 2016–2018 memory cycles showed 12–18 month overstays before sharp reversion, suggesting a disciplined stop-loss and defined-risk options are superior to full long exposure. Unintended consequence: heavy buy-side positioning could exacerbate downside when capex announcements crystallize.

Key Decisions for Investors

• Establish a tactical 1.5–2.5% portfolio long in SNDK ahead of the Dec 19 earnings print to capture guided upside; size with a hard stop at -20% post-earnings and trim to 1% if price rallies >20% intraday.
• Implement a defined-risk options hedge instead of naked stock: buy Jan 2026 260/320 call spread sized to equal 0.75% portfolio notional (cost-limited upside exposure) and simultaneously buy a Dec 19–30-day 200/170 put spread as earnings downside protection if holding the stock.
• Reduce discretionary exposure to DRAM- and capex-heavy peers (e.g., MU) by 20–30% for multi-quarter books; redeploy into NAND-cost-advantaged names (SNDK/Kioxia-exposed plays) and semicap suppliers that benefit from current utilization.
• Set monitoring triggers (act within 48–72 hours): cut SNDK exposure by 50% if spot NAND prices fall >15% from current levels or if announced industry wafer-start/capacity guidance implies >10% incremental NAND capacity for 2027; add opportunistically if such indicators do not appear by Q2 2026.